<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02263859</url>
  </required_header>
  <id_info>
    <org_study_id>IMT 2014-01</org_study_id>
    <nct_id>NCT02263859</nct_id>
  </id_info>
  <brief_title>Targeted Hypoglossal Neurostimulation Study #3</brief_title>
  <acronym>THN3</acronym>
  <official_title>ImThera Medical Targeted Hypoglossal Neurostimulation Study #3</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ImThera Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ImThera Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the benefits and risks of hypoglossal nerve
      stimulation with the ImThera Medical aura6000 System as a potential therapeutic option for
      individuals with moderate to severe OSA that have failed or do not tolerate PAP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are to evaluate the safety and effectiveness of the aura6000
      System for the treatment of moderate to severe obstructive sleep apnea (OSA) in individuals
      who have failed or do not tolerate positive airway pressure (PAP) therapy or have failed or
      are intolerant of or refuse indicated alternative OSA treatments (such as oral appliances,
      positional devices and conventional sleep surgeries). PAP failure is defined as an inability
      to eliminate OSA (AHI &gt; 20 despite PAP usage) and PAP intolerance is defined as: 1) inability
      to use PAP (greater than 5 nights per week of usage; usage defined as greater than 4 hours of
      use per night); or 2) unwillingness to use PAP (for example, a patient returns the PAP system
      after attempting to use it). The results of this study are anticipated to provide reasonable
      assurance of the safety and effectiveness of the aura6000 System when used as intended and to
      support the application for FDA Premarket Approval of the system.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in Apnea Hypopnea Index (AHI)</measure>
    <time_frame>Baseline to 4 months post-implant</time_frame>
    <description>Proportion of subjects who experience improvement in the apnea-hypopnea index (AHI) at the Month 4 visit as defined above in the AHI Responder definition.
It is hypothesized that the observed responder rate in the Treatment Group will be significantly greater than the responder rate in the Control Group at 4 months post-implant.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement in Oxygen Desaturation Index (ODI)</measure>
    <time_frame>Baseline to 4 months post-implant</time_frame>
    <description>Proportion of subjects who experience improvement in the oxygen desaturation index 4% (ODI 4%) at the Month 4 visit as defined above in the ODI Responder definition.
It is hypothesized that the observed responder rate in the Treatment Group will be significantly greater than the responder rate in the Control Group at 4 months post-implant.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety Analysis</measure>
    <time_frame>Baseline to 12 months post-implant</time_frame>
    <description>Estimate the incidence of serious adverse events (SAEs) related to the aura6000 device or procedure, including any unanticipated adverse device effects.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Long-term Responder Rate</measure>
    <time_frame>Baseline to 12 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Epworth Sleepiness Scale (ESS)</measure>
    <time_frame>Baseline to 4 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Functional Outcomes of Sleep (FOSQ)</measure>
    <time_frame>Baseline to 4 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in EuroQol 5 Dimensional (EQ-5D)</measure>
    <time_frame>Baseline to 4 months post-implant</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">141</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Treatment Group will be implanted with the aura6000 System and have therapy turned ON at the Month 1 follow-up visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The Control Group will be implanted with the aura6000 System and receive treatment as-usual, (i.e. any non-PAP, non-surgical OSA treatment including oral appliances and positional devices being used prior to enrollment in the study) until 14 days (washout period) prior to the Month 4 visit. At the Month 4 + 1 day follow-up visit, subjects in the Control Group will have therapy turned ON for the duration of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>aura6000 System</intervention_name>
    <description>The aura6000 System is intended to unilaterally stimulate the hypoglossal nerve which innervates the muscles of the tongue. The aura6000 System stimulates the hypoglossal nerve cyclically and continuously during sleep to maintain muscle tone of the tongue and upper airway during sleep. Stimulation is generated by a programmable, multi-current source, implantable neurostimulator (IPG) and delivered to the hypoglossal nerve by a lead with multi-contact cuff electrode (lead).</description>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>THN Therapy</other_name>
    <other_name>ImThera Medical</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years

          -  Individual has failed or does not tolerate PAP therapy

          -  Has failed or refuses alternative OSA treatments (e.g.surgery, oral appliances, and
             behavioral treatments)

          -  AHI ≥ 20 (Moderate to severe OSA)

        Exclusion Critera:

          -  Implanted with another active implantable device

          -  Body mass index (BMI) ≥ 35 kg/m²
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan R Schwartz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul Mason, PhD</last_name>
    <phone>858-259-2980</phone>
    <phone_ext>13</phone_ext>
    <email>pmason@imtheramedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>ENT Associates of San Diego</name>
      <address>
        <city>Chula Vista</city>
        <state>California</state>
        <zip>91911</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alen Putros</last_name>
      <email>aputrosent@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Paul Schalch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Tower ENT</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arash Shamsian</last_name>
      <email>cedars.sinai.sinus@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Martin L Hopp, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Sadaat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Alessi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Ruder, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SENTA Clinic</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Marsella</last_name>
      <email>smarsella.senta@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Brian Weeks, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharp Memorial Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Ear, Nose, and Throat Associates of South Florida</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33487</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Fonseca</last_name>
      <email>pfonseca@entsf.com</email>
    </contact>
    <investigator>
      <last_name>Nathan Nachlas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lee Mandel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BayCare Health System</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marietta Bibbs, BA, RPSGT, CCSH</last_name>
      <phone>727-725-6455</phone>
      <email>marietta.bibbs@baycare.org</email>
    </contact>
    <investigator>
      <last_name>Mitchell Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced ENT Asociates</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faraa Mobini, PA</last_name>
      <phone>404-943-0900</phone>
    </contact>
    <investigator>
      <last_name>Samuel A Mickelson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for ENT and Allergy</name>
      <address>
        <city>Carmel</city>
        <state>Indiana</state>
        <zip>46032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandon Boyd, MPAS, PA-C</last_name>
      <email>bboyd@centadocs.com</email>
    </contact>
    <investigator>
      <last_name>Tod Huntley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kentucky Research Group</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackie Bourke, RN, CCRC</last_name>
      <phone>502-479-1217</phone>
      <phone_ext>157</phone_ext>
      <email>jbourke@kyresearchgroup.com</email>
    </contact>
    <investigator>
      <last_name>David H Winslow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Gould, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Klopfer</last_name>
      <phone>410-550-4588</phone>
      <email>Tracy.Klopfer@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Alan R Schwartz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Eisele, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jersey Shore University Medical Center</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>ENT and Allergy Associates</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Zyla, RN, BSN</last_name>
      <phone>845-562-5941</phone>
      <phone_ext>7</phone_ext>
      <email>czyla@entandallergy.com</email>
    </contact>
    <investigator>
      <last_name>Ofer Jacobowitz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intrepid Research</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45245</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kiera Bartholomew</last_name>
      <phone>513-977-8891</phone>
      <email>kbartholomew@sleepmanagement.md</email>
    </contact>
    <investigator>
      <last_name>Bruce Corser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Hellmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio Sleep Medicine and Neurosciences Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyler Janz</last_name>
      <email>janz@musc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jonathan Ni</last_name>
      <email>nijo@musc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Neskey David, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shaun Nguyen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Methodist Physicians</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tate M Naylor</last_name>
      <phone>901-448-2284</phone>
      <email>tnaylor@uthsc.edu</email>
    </contact>
    <investigator>
      <last_name>Marion B Gillespie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FutureSearch Trials</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Ford</last_name>
      <email>kevinf@fstrials.com</email>
    </contact>
    <investigator>
      <last_name>John D. Hudson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Nason, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Texas Health Science Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Clinique Univ. Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Rombaux, MD, PhD</last_name>
      <email>philippe.rombaux@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Philippe Rombaux, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephane Attard</last_name>
      <email>stephane.attard@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Valerie Attali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chloe Bertolus, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Foch Hospital</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Flavie Barret, RN</last_name>
      <email>f.barret@hopital-foch.org</email>
    </contact>
    <contact_backup>
      <last_name>Michèle Lejaille</last_name>
      <email>m.lejaille@hopital-foch.com</email>
    </contact_backup>
    <investigator>
      <last_name>Frédéric Chabolle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Sleep Research</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>St. Joseph-Stift</name>
      <address>
        <city>Bremen</city>
        <zip>28209</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Ruprechts-Karls University</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Schmidt</last_name>
      <phone>49 1516 7409957</phone>
      <email>oliverschmidt@umm.de</email>
    </contact>
    <investigator>
      <last_name>Joachim T Mauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bnai Zion Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tzameret Avivi</last_name>
      <email>tzameret.avivi@b-zion.org.il</email>
    </contact>
    <investigator>
      <last_name>Arie Oliven, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ron Peled, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alex Brodsky, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital CUF Porto</name>
      <address>
        <city>Porto</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Carneiro</last_name>
      <email>ana.carneiro@jmellosaude.pt</email>
    </contact>
    <investigator>
      <last_name>Victor Certal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Portugal</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://THNStudy.com</url>
    <description>See if this study is right for you.</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2014</study_first_submitted>
  <study_first_submitted_qc>October 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2014</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obstructive Sleep Apnea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

